<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for ICLR</title>
    <link />
    <description>Headlines for ICON plc (ADR)</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Covance Beats Earnings, Rev, Ups View - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98679/covance-beats-earnings-rev-ups-view.aspx</link>
      <author>Zacks</author>
      <pubDate>Mon, 06 May 2013 08:15:01 GMT</pubDate>
    </item>
    <item>
      <title>ICON Public Limited Management Discusses Q1 2013 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1372991-icon-public-limited-management-discusses-q1-2013-results-earnings-call-transcript.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 25 Apr 2013 16:50:09 GMT</pubDate>
    </item>
    <item>
      <title>New Version of IMPACT CTMS in Market - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96457/new-version-of-impact-ctms-in-market.aspx</link>
      <author>Zacks</author>
      <pubDate>Fri, 05 Apr 2013 18:38:01 GMT</pubDate>
    </item>
    <item>
      <title>UPDATE: Jefferies Raises PT to $38 on ICON plc; Strategic Partnerships Paying Off</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/03/3409644/update-jefferies-raises-pt-to-38-on-icon-plc-strategic-p.aspx</link>
      <author>Benzinga</author>
      <pubDate>Tue, 12 Mar 2013 14:55:23 GMT</pubDate>
    </item>
    <item>
      <title>ICON Public Beats on Both Top and Bottom Lines</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/11/icon-public-beats-on-both-top-and-bottom-lines/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 11 Mar 2013 21:00:37 GMT</pubDate>
    </item>
    <item>
      <title>Long-Term Deals With Drug Makers Help Icon's Earnings</title>
      <link>http://www.fool.com/news/xt/nasdaq/www.nasdaq.com/article/longterm-deals-with-drug-makers-help-icons-earnings-cm224097.aspx</link>
      <author>Nasdaq</author>
      <pubDate>Wed, 06 Mar 2013 14:00:00 GMT</pubDate>
    </item>
    <item>
      <title>ICON Announces Appointment of Professor William Hall to Board of Directors</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/02/21/icon-announces-appointment-of-professor-william-ha/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 21 Feb 2013 12:50:12 GMT</pubDate>
    </item>
    <item>
      <title>UPDATE: ISI Group Reiterates Buy Rating, Raises PT on ICON plc on Solid 4Q Results</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/02/3349431/update-isi-group-reiterates-buy-rating-raises-pt-on-icon.aspx</link>
      <author>Benzinga</author>
      <pubDate>Wed, 20 Feb 2013 10:41:42 GMT</pubDate>
    </item>
    <item>
      <title>ICON Public Limited Management Discusses Q4 2012 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1203781-icon-public-limited-management-discusses-q4-2012-results-earnings-call-transcript.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 19 Feb 2013 14:40:31 GMT</pubDate>
    </item>
    <item>
      <title>Cross Country Healthcare Completes Sale of Clinical Trial Services Business to ICON</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/02/3343294/cross-country-healthcare-completes-sale-of-clinical-trial-services-business-to-ic.aspx</link>
      <author>Benzinga</author>
      <pubDate>Tue, 19 Feb 2013 06:18:51 GMT</pubDate>
    </item>
    <item>
      <title>ICON Reports Fourth Quarter 2012 Revenue of $300 Million, up 24% year on year, EPS of 34c and Full Y</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/02/19/icon-reports-fourth-quarter-2012-revenue-of-300-mi/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 19 Feb 2013 06:13:38 GMT</pubDate>
    </item>
    <item>
      <title>Cross Country Healthcare Completes Sale of Its Clinical Trial Services Business</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/02/19/cross-country-healthcare-completes-sale-of-its-cli/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 19 Feb 2013 06:12:57 GMT</pubDate>
    </item>
    <item>
      <title>It's Showtime for ICON Public</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/02/14/its-showtime-for-icon-public/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 14 Feb 2013 17:03:14 GMT</pubDate>
    </item>
    <item>
      <title>Top 4 Small-Cap Stocks In The Medical Laboratories &amp; Research Industry With The Highest Revenue Esti</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/trading-ideas/13/02/3307559/top-4-small-cap-stocks-in-the-medical-laboratories-research-industry-wit.aspx</link>
      <author>Benzinga</author>
      <pubDate>Wed, 06 Feb 2013 03:08:59 GMT</pubDate>
    </item>
    <item>
      <title>ICON Announces the Commencement of Direct Trading on NASDAQ</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/02/05/icon-announces-the-commencement-of-direct-trading-/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 05 Feb 2013 06:17:53 GMT</pubDate>
    </item>
    <item>
      <title>ICON Begins Direct Trading on NASDAQ</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/02/3303644/icon-begins-direct-trading-on-nasdaq.aspx</link>
      <author>Benzinga</author>
      <pubDate>Tue, 05 Feb 2013 06:06:40 GMT</pubDate>
    </item>
    <item>
      <title>Jefferies Reiterates Buy Rating, $32 PT on ICON plc on Clinical Trial Staffing Acquisition</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/02/3301437/jefferies-reiterates-buy-rating-32-pt-on-icon-plc-on-cli.aspx</link>
      <author>Benzinga</author>
      <pubDate>Mon, 04 Feb 2013 13:17:08 GMT</pubDate>
    </item>
    <item>
      <title>A Peek Into The Market Before The Trading Starts</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/02/3299797/a-peek-into-the-market-before-the-trading-starts.aspx</link>
      <author>Benzinga</author>
      <pubDate>Mon, 04 Feb 2013 07:10:52 GMT</pubDate>
    </item>
    <item>
      <title>UPDATE: Sterne Agee Reiterates Neutral Rating, Raises PT on ICON plc</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/01/3240523/update-sterne-agee-reiterates-neutral-rating-raises-pt-o.aspx</link>
      <author>Benzinga</author>
      <pubDate>Mon, 14 Jan 2013 14:11:36 GMT</pubDate>
    </item>
    <item>
      <title>Strengthening Moats Mean Improving Returns For CRO Investors</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1088091-strengthening-moats-mean-improving-returns-for-cro-investors.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 31 Dec 2012 08:57:57 GMT</pubDate>
    </item>
  </channel>
</rss>
